Company / Working Capital per Share
Ligand Pharmaceuticals, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$41.60
FY2025
5-year range
$9.83 / $41.60
FY2021-FY2025
Trend
+148.0%
vs FY2024
Sector context
#8 of 210
Health Care
What the data says
Among 210 Health Care companies, Ligand Pharmaceuticals, Inc. is in the top 4% for working capital per share. Working Capital per Share has increased for 3 consecutive years, from $9.83 in FY2022 to $41.60 in FY2025.
Based on SEC 10-K filings.
41.60 in FY2025 with a 5-year CAGR of +11.8%. Top quartile in the Health Care sector.
Improved from $13.02 to $41.60 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +61.8%
- 5-Year CAGR
- +11.8%
- 10-Year CAGR
- -
Sector benchmark
-71.7% below sector average
Key checks
Key Insights
- Ligand Pharmaceuticals, Inc.'s working capital per share has grown for 3 consecutive years.
- In FY2025, working capital per share increased 148.0% year-over-year.
- Ranks #8 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $41.60 | +148.0% |
| FY2024 | $16.77 | +28.8% |
| FY2023 | $13.02 | +32.4% |
| FY2022 | $9.83 | -62.6% |
| FY2021 | $26.31 | +10.5% |
| FY2020 | $23.80 | -55.3% |
| FY2019 | $53.29 | +43.0% |
| FY2018 | $37.27 | +42296.5% |
| FY2017 | -$0.09 | +97.2% |
| FY2016 | -$3.21 | -675.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026